Table 2 Demographic and clinicopathologic data on patients with ALK-RCC.
Case No. | Age (years) | Gender | Size (mm) | Stage | Follow-up (mo) | Outcome | Treatment |
|---|---|---|---|---|---|---|---|
1 | 33 | F | 25 | pT1a | 40 | ANED | RN |
2 | 51 | F | 41 | pT1b | NA | NA | RN |
3 | 25 | F | 20 | pT1a | 153 | ANED | PN |
4 | 48 | F | 26 | pT1a | 20 | ANED | PN |
5 | 54 | M | 22 | pT1a | NA | NA | PN |
6 | 56 | M | 25 | pT3a | 66 | AWD (cervical, mediastinal, brain MS) | RN |
7 | 42 | M | 49 | pT3a | NA | NA | RN |
8 | 58 | F | 70 | pT3a | 2 | ANED | RN |
9 | 43 | M | 38 | pT3a | 12 | ANED | RN |
10 | 40 | F | 17 | pT1a | 8 | ANED | PN |
11 | 38 | M | 20 | pT1a | 23 | ANED | PN |
12 | 68 | F | 25 | pT1a | 14 | ANED | PN |
